Aetna GLP-1 Coverage: What You Need to Know
If you have Aetna insurance and you are considering a GLP-1 medication like Wegovy or Zepbound for weight loss, the first thing to understand is that coverage varies significantly by plan type. Aetna offers fully insured plans that follow their standard clinical policies, but they also administer self-funded employer plans where the employer decides what to cover. That distinction matters more than anything else when it comes to GLP-1 coverage.
As of early 2026, Aetna's standard commercial formulary includes Wegovy and, on select plans, Zepbound. But inclusion on the formulary does not mean automatic approval. You will almost certainly need prior authorization.
Aetna's Prior Authorization Requirements
To get approved for a GLP-1 weight loss medication through Aetna, you typically need to meet all of the following criteria:
- BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition (type 2 diabetes, hypertension, dyslipidemia, or obstructive sleep apnea)
- Documentation of a prior weight management attempt lasting at least 3 to 6 months, which can include a structured diet program, behavioral counseling, or a previous medication trial
- Prescriber must be a licensed physician or advanced practice provider, and some plans require a specialist referral
Aetna's clinical policy bulletin (CPB 0784) outlines these requirements in detail. Your provider should reference this document when submitting the prior authorization.
Which Aetna Plans Cover GLP-1s?
Here is a general breakdown of coverage likelihood by plan type:
| Plan Type | Wegovy Coverage | Zepbound Coverage |
|---|---|---|
| Aetna Commercial (fully insured) | Often covered with PA | Varies by formulary |
| Aetna Medicare Advantage | Covered for diabetes indication only (as Ozempic/Mounjaro) | Limited |
| Self-funded employer plans | Depends entirely on employer | Depends entirely on employer |
| Aetna Student Health | Rarely covered | Rarely covered |
| Aetna Medicaid managed care | State-dependent | State-dependent |
The most reliable way to check is to log into your Aetna member portal, navigate to the pharmacy section, and search for the specific drug name. You can also call the member services number on the back of your card.
What GLP-1 Medications Does Aetna's Formulary Include?
Aetna's standard 2026 commercial formulary generally includes:
- Wegovy (semaglutide 2.4 mg) for chronic weight management
- Saxenda (liraglutide 3.0 mg) for chronic weight management
- Ozempic (semaglutide 1.0 mg / 2.0 mg) for type 2 diabetes only
- Mounjaro (tirzepatide) for type 2 diabetes only
- Zepbound (tirzepatide) for chronic weight management, on select plans
Keep in mind that formulary placement affects your copay. Wegovy is typically on a specialty tier, which means higher out-of-pocket costs, sometimes $150 to $300 per month even with coverage.
How Much Will You Pay Out of Pocket?
Even with Aetna coverage, costs vary based on your plan's tier structure:
- Preferred brand tier: $50 to $100/month copay
- Specialty tier: $150 to $300/month copay or 20-30% coinsurance
- Out-of-pocket maximum: Once you hit your plan's annual max (typically $4,000 to $8,000 for individuals), the plan covers 100%
Without insurance, Wegovy costs roughly $1,300 to $1,400 per month at retail. Zepbound runs about $1,000 to $1,100 per month. So even imperfect coverage saves you hundreds each month.
How to Appeal an Aetna GLP-1 Denial
If Aetna denies your prior authorization, do not give up. Denials are common for GLP-1 medications, and many are overturned on appeal. Here is the process:
- Read the denial letter carefully. It will state the specific reason, such as "does not meet medical necessity criteria" or "excluded benefit under your plan."
- If the denial is for medical necessity, ask your doctor to write a detailed letter of appeal that addresses each stated reason. Include BMI history, lab work, records of prior weight loss attempts, and any comorbidities.
- Submit the internal appeal within 180 days. Aetna must respond within 30 days for standard appeals or 72 hours for urgent/expedited appeals.
- If the internal appeal is denied, request an external review. An independent reviewer not affiliated with Aetna will evaluate the case. Many states require this option for fully insured plans.
- Contact your state insurance commissioner if you believe the denial violates state mandates.
According to industry data, roughly 40-50% of GLP-1 prior authorization denials are overturned on first appeal when supported by thorough documentation.
Tips for Getting Aetna to Cover Your GLP-1
- Ask your doctor to use diagnosis codes for both obesity (E66.01) and any comorbidities
- Document every prior weight loss attempt in your medical records before submitting the PA
- If your employer plan excludes anti-obesity medications, ask your HR department whether they would consider adding coverage during the next benefits cycle
- Consider using the Wegovy savings card or Zepbound savings program to reduce your copay even further
Bottom Line
Aetna does cover GLP-1 weight loss medications for many members, but approval requires meeting clinical criteria and navigating the prior authorization process. The biggest variable is your specific plan type. Check your formulary, understand the requirements, and work closely with your prescribing provider to submit a strong prior authorization request.
If you need help finding a GLP-1 clinic that works with Aetna insurance, search our directory to find providers near you who can handle the prior authorization process on your behalf.